MAPT and Anxiety: Most significantly, we observe AAV9 delivery of FAF2PS in the PS19 mouse model attenuated microgliosis, reduced phosphorylated and insoluble tau levels, hindered the production of tau seeds, restored decreased anxiety and conferred a cognitive benefit in contextual fear conditioning consistent with improved hippocampal function (Figure 6 and 7).